BioSpace News Archive

Study showed oxygenation improvement and increased out-of-body perfusion duration

Genesis Innovation Group’s Shoulder Innovations is focused on human centered design.

BlueRock Therapeutics, LP announced its participation in the inaugural Cell & Gene Meeting on the Mediterranean to be held April 23-25 in Barcelona, Spain.

Enrollment Sufficient to Support the Interim Efficacy Analysis

Public Appeal Process Completed – Facility Construction to Begin in May 2019

Having established first-in-industry RNA-targeted Small Molecule (rSM) platform, Arrakis will focus pipeline in oncology and genetically validated targets in other diseases

IMV Inc. announced that two of its abstracts have been accepted for presentation at the upcoming 2019 American Society of Clinical Oncology Annual Meeting, which takes place May 31 – June 4 in Chicago, IL.

Experienced CEO brings expertise in product development, cell and gene therapies, and public biotechnology companies as Obsidian positions itself for future growth

Soliton, Inc. (NASDAQ: SOLY) (“Soliton” or the “Company”), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center (“MD Anderson”), today announced that its Executive Chairman, Walter Klemp, will give a live interview on Yahoo Finance on Monday, May 13, 2019.

Ipsen’s Rare Diseases portfolio significantly enhanced with late-stage drug candidate, palovarotene, for the treatment of rare bone disorders in adult and pediatric patients